Bioasis sells royalty rights to four drugs for $1.2M
A California company has paid Bioasis Technologies$1.2 million for a royalty interest in four rare disease drugs the Guilford biotech is developing with an Italian...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
A California company has paid Bioasis Technologies$1.2 million for a royalty interest in four rare disease drugs the Guilford biotech is developing with an Italian...
Pfizer Inc. and BioNTech report that their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of...
Hyperfine has won the American College of Emergency Physicians 2020 incubatED Medical Device Innovation Challenge, recognizing the company’s Swoop™ Portable MR Imaging System. “Portable MR...
Boehringer Ingelheim has appointed Yew Looi Liew (YL) President of U.S. Human Pharma at its U.S. headquarters. In his new role, Mr. Liew is responsible for...
Vanessa Research has been granted a positive orphan drug opinion by the European Medicines Agency for the drug Shylicine™ (patent pending). The drug is used to treat...
Taconic Biosciences reports the immediate availability of humanized ACE2 mouse model for COVID-19 research. The SARS-CoV-2 virus, which causes COVID-19, uses the ACE2 receptor to enter cells....
The FDA has greenlighted the application from BioXcel Therapeutics to begin a clinical trial on its agitation drug for patients with delirium. This would be the...
Biotech firms Cara Therapeutics and SpringWorks Therapeutics have announced licensing and acquisition deals that could be worth several hundred million dollars. Cara signed a deal with Vifor Pharma for the...
CaroGen reports that significant progress has been made in collaboration with Wayne State University in developing CARG-2020 for potential treatment of patients with ovarian cancer and other...
Rocky Hill-based Lumeda, a startup that is developing an optical device to target cancer-killing laser light during lung cancer surgery, has named its first CEO. Alexander...